Chester County News and Community Website
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it will release its third-quarter 2025 financial results on Tuesday, November 4, 2025, ahead of the opening of U.S. financial markets.
Madrigal Pharmaceuticals to Report Third-Quarter 2025 Results on November 4 Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced that it has granted equity awards to 19 new non-executive employees as part of its 2025 Inducement Plan. The awards, approved …
Madrigal Pharmaceuticals Grants Equity Awards to New Employees Under 2025 Inducement Plan Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced that on October 1, 2025, it granted equity awards to 27 new non-executive employees as inducement grants under the company’s 2025 …
Madrigal Pharmaceuticals Grants Equity Awards to New Employees Under 2025 Inducement Plan Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it has granted equity awards to 76 new non-executive employees as part of its 2025 Inducement Plan. The awards were approved …
Madrigal Pharmaceuticals Grants Equity Awards to 76 New Employees Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it has granted equity inducement awards to 17 new non-executive employees under the company’s 2025 Inducement Plan.
Madrigal Pharmaceuticals Grants Equity Awards to New Employees Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it will present at the Morgan Stanley 23rd Annual Global Health Care Conference on Monday, September 8, 2025, at 7:45 a.m. …
Madrigal Pharmaceuticals to Present at Morgan Stanley Global Health Care Conference Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it has granted equity inducement awards to 11 new non-executive employees as part of its 2025 Inducement Plan. The awards, approved …
Madrigal Pharmaceuticals Grants Equity Awards to New Employees Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced that the European Commission (EC) has granted conditional marketing authorization for Rezdiffra (resmetirom), marking the first approved treatment in the …
Madrigal Pharmaceuticals Secures EU Approval for First-Ever MASH Therapy Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 10:30 a.m. EDT.
Madrigal Pharmaceuticals to Present at Canaccord Genuity Growth Conference Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it has granted equity awards to 26 newly hired non-executive employees as part of its 2025 Inducement Plan. The awards, approved …
Madrigal Pharmaceuticals Grants Equity Awards to New Hires Under Inducement Plan Read More